6-161428757-T-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_004562.3(PRKN):c.1084-41880A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.752 in 152,126 control chromosomes in the GnomAD database, including 43,147 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.75 ( 43147 hom., cov: 33)
Consequence
PRKN
NM_004562.3 intron
NM_004562.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.53
Publications
4 publications found
Genes affected
PRKN (HGNC:8607): (parkin RBR E3 ubiquitin protein ligase) The precise function of this gene is unknown; however, the encoded protein is a component of a multiprotein E3 ubiquitin ligase complex that mediates the targeting of substrate proteins for proteasomal degradation. Mutations in this gene are known to cause Parkinson disease and autosomal recessive juvenile Parkinson disease. Alternative splicing of this gene produces multiple transcript variants encoding distinct isoforms. Additional splice variants of this gene have been described but currently lack transcript support. [provided by RefSeq, Jul 2008]
PRKN Gene-Disease associations (from GenCC):
- autosomal recessive juvenile Parkinson disease 2Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp
- Parkinson diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- young-onset Parkinson diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.858 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.752 AC: 114316AN: 152008Hom.: 43101 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
114316
AN:
152008
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.752 AC: 114420AN: 152126Hom.: 43147 Cov.: 33 AF XY: 0.751 AC XY: 55846AN XY: 74344 show subpopulations
GnomAD4 genome
AF:
AC:
114420
AN:
152126
Hom.:
Cov.:
33
AF XY:
AC XY:
55846
AN XY:
74344
show subpopulations
African (AFR)
AF:
AC:
31605
AN:
41506
American (AMR)
AF:
AC:
12267
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
AC:
2244
AN:
3472
East Asian (EAS)
AF:
AC:
4549
AN:
5176
South Asian (SAS)
AF:
AC:
3772
AN:
4818
European-Finnish (FIN)
AF:
AC:
7421
AN:
10570
Middle Eastern (MID)
AF:
AC:
209
AN:
294
European-Non Finnish (NFE)
AF:
AC:
50120
AN:
67998
Other (OTH)
AF:
AC:
1582
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1491
2983
4474
5966
7457
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
856
1712
2568
3424
4280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.